These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16553533)

  • 1. Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents.
    Alderman J; Wolkow R; Fogel IM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):117-29. PubMed ID: 16553533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
    Cook EH; Wagner KD; March JS; Biederman J; Landau P; Wolkow R; Messig M
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1175-81. PubMed ID: 11589530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
    JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
    Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sertraline treatment of children and adolescents with major depressive disorder.
    Rynn M; Wagner KD; Donnelly C; Ambrosini P; Wohlberg CJ; Landau P; Yang R
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):103-16. PubMed ID: 16553532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
    Kronig MH; Apter J; Asnis G; Bystritsky A; Curtis G; Ferguson J; Landbloom R; Munjack D; Riesenberg R; Robinson D; Roy-Byrne P; Phillips K; Du Pont IJ
    J Clin Psychopharmacol; 1999 Apr; 19(2):172-6. PubMed ID: 10211919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
    Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
    Wagner KD; Cook EH; Chung H; Messig M
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S53-60. PubMed ID: 12880500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
    Alderman J; Wolkow R; Chung M; Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):386-94. PubMed ID: 9549959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
    Koran LM; Hackett E; Rubin A; Wolkow R; Robinson D
    Am J Psychiatry; 2002 Jan; 159(1):88-95. PubMed ID: 11772695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder.
    Bisserbe J; Lane R; Flament M;
    Eur Psychiatry; 1997; 12(2):82-93. PubMed ID: 19698511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram treatment of children and adolescents with obsessive-compulsive disorder: a preliminary report.
    Mukaddes NM; Abali O; Kaynak N
    Psychiatry Clin Neurosci; 2003 Aug; 57(4):405-8. PubMed ID: 12839522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
    Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
    J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
    Tini E; Smigielski L; Romanos M; Wewetzer C; Karwautz A; Reitzle K; Correll CU; Plener PL; Malzahn U; Heuschmann P; Unterecker S; Scherf-Clavel M; Rock H; Antony G; Briegel W; Fleischhaker C; Banaschewski T; Hellenschmidt T; Imgart H; Kaess M; Kölch M; Renner T; Reuter-Dang SY; Rexroth C; Schulte-Körne G; Theisen F; Fekete S; Taurines R; Gerlach M; Egberts KM; Walitza S
    Compr Psychiatry; 2022 May; 115():152301. PubMed ID: 35248877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine in acute treatment of children and adolescents with obsessive-compulsive disorder: a systematic review and meta-analysis.
    Maneeton N; Maneeton B; Karawekpanyawong N; Woottiluk P; Putthisri S; Srisurapanon M
    Nord J Psychiatry; 2020 Oct; 74(7):461-469. PubMed ID: 32242450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.